Jason Andrade Profile
Jason Andrade

@DrJasonAndrade

Followers
8K
Following
36K
Media
923
Statuses
4K

Cardiologist @VCHhealthcare / Clinical Faculty @UBCDoM / Co-Chair @SCC_CCS AF Guidelines / Device Chair @CHRS_SCR

Canada
Joined November 2017
Don't wanna be here? Send us removal request.
@DrJasonAndrade
Jason Andrade
3 years
Here the link to our study examining the effect of first-line ablation vs AAD on AF progression. Thanks to @AHAScience for welcoming me back to present the results, and to @NEJM for the simultaneous publication. @CCI_CIC @UBCDoM @CHRS_SCR @SCC_CCS .
Tweet card summary image
nejm.org
Atrial fibrillation is a chronic, progressive disorder, and persistent forms of atrial fibrillation are associated with increased risks of thromboembolism and heart failure. Catheter ablation as in...
20
108
331
@DrJasonAndrade
Jason Andrade
19 hours
I personally think this is a big deal. We act like every recurrence on a KM curve is of equal importance, but the reality is earlier recurrences are qualitatively different from later recurrences. To the extent that the recurrences in the first 6 months post ablation are the.
0
9
38
@grok
Grok
7 days
Join millions who have switched to Grok.
262
515
4K
@DrJasonAndrade
Jason Andrade
4 days
RT @pan_pantelidis: Live at #ESCCongress Paris:.Guidelines in Practice – 2024 ESC Guidelines for Persistent #AFib. 🔹 Jason Andrade – case p….
0
3
0
@DrJasonAndrade
Jason Andrade
4 days
RT @simovicst: How to put #AFib 2024 Guidelines in Practice with @DrJasonAndrade @purerfellner & @AndreaSarkozy session is packed . 📍Room:….
0
4
0
@DrJasonAndrade
Jason Andrade
12 days
RT @JICE_EP: 🚨Latest #FreeRead Article in.@JICE_EP. Regional Disparities in the Care & Outcomes of Atrial Fibrillation Patients in a Univer….
0
2
0
@DrJasonAndrade
Jason Andrade
17 days
RT @gautamsand: 📢New Meta-analysis: Rate vs Rhythm Control in AF and Risk of Syncope, Falls & Pacing @hrs_journal @HRSonline @MoShurrabMD….
0
12
0
@DrJasonAndrade
Jason Andrade
18 days
RT @DilawriCVI: Helen Li Pak Tong reflects on her experience as a patient of DCI's @DrJasonAndrade, a leading cardiac electrophysiologist:….
0
1
0
@DrJasonAndrade
Jason Andrade
1 month
On behalf of the @SCC_CCS @CHRS_SCR Device Advisory Committee, please find attached the Canadian Guidance for the 2025 Boston Scientific RELIANCE ePTFE ICD lead advisory.
Tweet media one
Tweet media two
1
6
28
@DrJasonAndrade
Jason Andrade
1 month
It’s an exciting start to #EASThigh in Canada. We are proud to partner with @afnet_ev on this international collaboration, and are looking forward to expanding the study nationally. @DilawriCVI @ubc_cci.
@afnet_ev
AFNET
1 month
🎉We’re excited to share that #EASThigh has officially started in #Canada — with the first #patient enrolled at Vancouver General Hospital!.A huge thank you and congratulations to PI @DrJasonAndrade and his dedicated team for making this possible. 👏@Medtronic #AFNET #afib
Tweet media one
0
2
10
@DrJasonAndrade
Jason Andrade
2 months
There a remarkably consistent benefit to catheter ablation in terms of being a disease modifying therapy.
@hrs_journal
HeartRhythm
2 months
Catheter Ablation of Paroxysmal Atrial Fibrillation and Disease Progression: Magnitude of the anti-progression effect and role of intervention timing. @KarimBenali42 @DrJasonAndrade.
Tweet media one
1
16
45
@DrJasonAndrade
Jason Andrade
2 months
RT @DilawriCVI: It is with great enthusiasm that we introduce the Dilawri Cardiovascular Institute! The creation of DCI at Vancouver Genera….
0
3
0
@DrJasonAndrade
Jason Andrade
3 months
We looked at 42 trials of AF ablation using multiple energy sources and aggregated recurrence timing. Recurrence I non uniform and most are detected early. Shortening follow-up can enhance knowledge to practice and reduce trial costs without affecting outcomes. @DilawriCVI.
@hrs_journal
HeartRhythm
3 months
Time Course of Recurrent Arrhythmias in Clinical Trials of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Pooled Analysis. @DrJasonAndrade .
0
3
19
@DrJasonAndrade
Jason Andrade
3 months
RT @RIOCongress: 💫 @DrJasonAndrade and @DrRoderickTung discuss the limitations of MRI in detecting subtle atrial scarring following pulsed….
0
7
0
@DrJasonAndrade
Jason Andrade
3 months
It was an honour to lead the fantastic collaboration with key clinicians from North, Central, and South America. There is a lot of opportunity to improve outcomes for our patients living with AF. @DilawriCVI @VGHFdn @ubc_cci.
@LAHRSonline1
LAHRS
4 months
🆕🆕ATRIAL FIBRILLATION IN THE AMERICAS 🌎.Regional variations and challenges in the management of atrial fibrillation are present throughout the Americas. @DrJasonAndrade @jcdiaz1234 @EP_mom1 @CarlChiefCard @nlcabanillas @TheLancet .
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
4
16
@DrJasonAndrade
Jason Andrade
4 months
Happy to share our recent article examining Atrial fibrillation in the Americas, which was published in The Lancet Regional Health.
1
8
32
@DrJasonAndrade
Jason Andrade
4 months
RT @afnet_ev: Thank you to all participants for your active contribution to the 10th #AFNET #EHRA_ESC Consensus Conference — Your presence….
0
8
0
@DrJasonAndrade
Jason Andrade
4 months
RT @HRSonline: NEW EPISODE OF THE LEAD!. [Ep. 101] A Discussion of Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation….
0
6
0
@DrJasonAndrade
Jason Andrade
4 months
If you’re free come learn how AI can enable clinical trials by providing expert adjudication of arrhythmia outcomes. E.g. 1 year of follow-up in CIRCA-DOSE generated 32000 arrhythmia events needing 80k adjudications, which is labour intensive. AI is poised to be transformative
Tweet media one
0
1
12
@DrJasonAndrade
Jason Andrade
4 months
RT @CircAHA: The ICM monitored Phase 2 of ADVANTAGE AF met safety and efficacy endpoints and supports the relationship of AF burden and HCU….
Tweet card summary image
ahajournals.org
BACKGROUND: There are sparse high-quality safety and effectiveness data for pulsed field ablation (PFA) of persistent atrial fibrillation (PerAF), in which lesions beyond pulmonary vein isolation...
0
4
0
@DrJasonAndrade
Jason Andrade
4 months
It’s amazing to see consistent information across populations. Recapitulating data from CIRCA-DOSE the recent Advantage AF showed AF burden <0.1% & AF episodes less <1h on follow-up had HCU comparable to no AF. Same threshold paroxysmal and Persistent AF.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
16
44